Parexel launches medical writing solutions business

Paraexel’s new medical writing solutions team are set to provide a wide variety of communication services throughout the drug development and commercialisation process. The offering can be a functional service project or a part of a larger strategic partnership. The team of more than 800 employees across the world will develop high quality documents including protocols, new drug applications, medical education materials and regulatory authority meeting documents.

Vice president and head of the writing solutions at Parexel Julia Cooper commented “As the drug development journey continues to evolve with the advancements in trial design and technology, and regulatory requirements change, it is vital that clients have access to highly-experienced medical writers who can communicate with all stakeholders in an integrated way, eliminating silos and telling a more holistic story through each stage of development and commercialisation. Our deep cross-functional expertise enables us to optimise the medical writing process for our clients, and ultimately allows them to engage more effectively with audiences that are critical in bringing new therapies to market.”